SPRY
ARS Pharmaceuticals Inc

2,436
Mkt Cap
$1.1B
Volume
1.1M
52W High
$18.90
52W Low
$6.66
PE Ratio
-13.12
SPRY Fundamentals
Price
$10.75
Prev Close
$11.09
Open
$11.15
50D MA
$9.96
Beta
1.25
Avg. Volume
1.58M
EPS (Annual)
$0.0781
P/B
7.12
Rev/Employee
$557,181.25
Loading...
Loading...
News
all
press releases
ARS Pharmaceuticals (NASDAQ:SPRY) Shares Down 12.3% - Should You Sell?
ARS Pharmaceuticals (NASDAQ:SPRY) Shares Down 12.3% - Time to Sell...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
SPRY Makes Bullish Cross Above Critical Moving Average
In trading on Friday, shares of ARS Pharmaceuticals Inc (Symbol: SPRY) crossed above their 200 day moving average of $12.77, changing hands as high as $13.01 per share. ARS Pharmaceuticals Inc shares...
Nasdaq News: Markets·7d ago
News Placeholder
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the eight analysts that are currently covering the company...
MarketBeat·15d ago
News Placeholder
ARS Pharmaceuticals (NASDAQ:SPRY) Shares Up 3.4% - Time to Buy?
ARS Pharmaceuticals (NASDAQ:SPRY) Trading 3.4% Higher - Here's Why...
MarketBeat·18d ago
News Placeholder
ARS Pharmaceuticals (NASDAQ:SPRY) Trading 7.9% Higher - What's Next?
ARS Pharmaceuticals (NASDAQ:SPRY) Shares Up 7.9% - Should You Buy...
MarketBeat·28d ago
News Placeholder
ARS Pharmaceuticals (NASDAQ:SPRY) Stock Price Up 6.3% - Time to Buy?
ARS Pharmaceuticals (NASDAQ:SPRY) Trading 6.3% Higher - What's Next...
MarketBeat·1mo ago
News Placeholder
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Receives Consensus Rating of "Moderate Buy" from Analysts
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the eight ratings firms that are presently covering the stock...
MarketBeat·1mo ago
News Placeholder
ARS Pharmaceuticals (NASDAQ:SPRY) Shares Up 8.1% - Here's What Happened
ARS Pharmaceuticals (NASDAQ:SPRY) Stock Price Up 8.1% - What's Next...
MarketBeat·1mo ago
News Placeholder
Franklin Resources Inc. Sells 28,789 Shares of ARS Pharmaceuticals, Inc. $SPRY
Franklin Resources Inc. trimmed its stake in shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY - Free Report) by 1.5% during the second quarter, according to the company in its most recent disclosure...
MarketBeat·2mo ago
News Placeholder
ARS Pharmaceuticals (NASDAQ:SPRY) Raised to Hold at Zacks Research
Zacks Research upgraded shares of ARS Pharmaceuticals from a "strong sell" rating to a "hold" rating in a research report on Thursday...
MarketBeat·2mo ago
<
1
2
...
>

Latest SPRY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.